2011年三季报业绩:公司前三季度主营收入、净利润分别为36.29亿、3.50亿元，同比增长10.8%、44.2%；营业利润4.24亿元，同比增长44.1%。EPS0.67元。ROE9.4%。基本符合我们预期的增长。每股经营性现金流0.56元，现金流情况良好 ... 海正药业：费用控制出色业绩夯实向上 增持评级
Subscribe to:
Post Comments (Atom)
Popular Posts
-
LONDON, Sept 29 (Reuters) - OPEC oil output is expected to rise in September to its highest in almost three years due to higher supplies fr...
No comments:
Post a Comment